10:42 AM EDT, 07/09/2025 (MT Newswires) -- Ernexa Therapeutics ( ERNA ) on Wednesday said it regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Stock Market.

The company said it received formal notice from Nasdaq on July 1 stating that it now meets the minimum bid price requirement.

Shares of Ernexa Therapeutics ( ERNA ) were up 1.6% in recent trading.

Price: 1.95, Change: +0.03, Percent Change: +1.56